NewsRamp Science, Exploration and Discovery Podcast

Dr. Phillip D. Zamore, renowned for his work in RNA biology and gene silencing mechanisms, has joined TransCode Therapeutics' Scientific Advisory Board. His expertise in RNA interference will enhance the company's RNA-targeted cancer therapy programs, focusing on metastatic tumors such as the lead candidate, TTX-MC138, which targets microRNA-10b overexpressing tumors.

Telomir Pharmaceuticals secures a $3 million equity investment for their age-reversal pipeline, while Nicola Mining Inc. starts processing ore at their upgraded mill and Aston Bay Holdings Ltd. announces plans for their 2025 exploration program. Lionheart Health, Inc. is a semi-finalist in the XPRIZE Healthspan Competition, and NRx Pharmaceuticals Inc. is making strides in innovative therapies for...

Recent research highlights potential links between the Epstein-Barr virus and Multiple Sclerosis, advancements in MS treatment development by Quantum BioPharma Ltd., efforts by the American Heart Association to integrate food as medicine interventions, the need for multi-antigen COVID-19 vaccines by GeoVax Labs, Inc., business updates from BioCorRx Pharmaceuticals Inc., insights from a multidiscip...

CNS Pharmaceuticals Inc. reported a Q1 2025 net loss of $4.3 million due to increased R&D spending for its Berubicin trial. The company is focusing on advancing TPI 287, a novel taxane for glioblastoma, with plans for a Phase 2 study in late 2025. CNS has secured Orphan Drug Designation for TPI 287 and is well-funded with $13.1 million in cash and $5 million raised in May, supporting operations in...

Soligenix is progressing with its Phase 3 CTCL study and vaccine programs, NRx Pharmaceuticals has secured funding for its interventional psychiatry clinic network, Telomir Pharmaceuticals has unveiled a new antimicrobial drug candidate, Creative Biolabs is enhancing antibody functionality, Tevard Biosciences is showing promising results in DMD therapy, Aston Bay Holdings is partnering for project...

This podcast episode covers updates from various companies, including Foremost Clean Energy's geophysical survey for uranium, Telomir Pharmaceuticals' expansion into rare diseases, Soligenix's government funding and vaccine developments, GeoVax Labs' patent expansion, Giant Mining Corp.'s drilling progress in Nevada, HeartBeam Inc.'s new patents for cardiac monitoring, and research on the impact o...

The podcast covers a wide range of topics, including pharmaceutical advancements such as NRx Pharmaceuticals' patent application for a preservative-free ketamine formulation and GeoVax Labs' progress in vaccine development. Additionally, updates on mining exploration projects by companies like Goliath Resources and ESGold Corp are discussed. The importance of research in various sectors, from infe...

Aditxt Inc. will be hosting Dr. Charles Howe from the Mayo Clinic in their upcoming Weekly Update, where he will discuss key findings from a preclinical study of ADI-100. The update will also feature Aditxt's Chief Innovation Officer and Co-CEO of Adimune, highlighting advancements in immune modulation therapy. Aditxt is an innovation platform focused on health collaborations, with programs in imm...

Vycor Medical, Inc. experienced a 10 percent increase in revenue in 2024, driven by growth in US hospital sales. The company also published new studies showcasing the effectiveness of its ViewSite Brain Access System. Vycor Medical aims to accelerate growth through strategic acquisitions and partnerships with the help of Maxim Group LLC.

GeoVax Labs, Inc. will be presenting clinical data at two upcoming industry events in April. Dr. Don J. Diamond will discuss Phase 2b study results comparing GeoVax's COVID-19 vaccine candidate to an approved vaccine at the World Vaccine Congress. Dr. J. Marc Pipas will present on Gedeptin therapy for solid tumors at the American Association of Cancer Research. GeoVax is focused on developing vacc...

A groundbreaking study conducted in South Korea reveals a significant increase in heart inflammation risk, specifically myocarditis and pericarditis, among young men after receiving mRNA COVID-19 vaccines. The research challenges the notion that vaccines are safer than the virus itself and emphasizes the need for transparency and awareness of potential risks associated with mRNA vaccines.

Creative Biolabs is expanding its Bacteroides platform to offer strain capture and delivery, identification services using advanced techniques, and in vitro and in vivo assessments. With a focus on biosafety, they also provide laboratory-scale production services. The goal is to provide globally accessible resources and support for probiotic development.

Palatin Technologies has made significant advancements in the fields of obesity, colitis, and kidney disease. Their Phase 2 studies have shown positive outcomes, including weight reduction in obesity patients, improved kidney function in diabetic kidney disease, and promising results in ulcerative colitis patients. Major pharmaceutical companies are showing interest, with potential licensing deals...

Quantum Critical Metals Corp. has reported significant drill core assays at its Discovery project in Quebec, revealing elevated levels of gallium, rubidium, niobium, cesium, and tantalum. The project, initially explored for gold, has now unveiled a second gallium-rubidium-cesium discovery. The company also identified indicators of a potential VMS system and plans to conduct further reviews and pro...

Hydromer, Inc. has reported a 12 percent decline in total revenue for the year ended December 31, 2024, attributed to legacy program attrition and a lack of new product introductions. However, the company achieved a normalized net loss and is focusing on streamlining operations, improving cost efficiency, and developing new products to drive revenue growth in high-demand markets. CEO Michael Torti...

A study by HR.com's HR Research Institute reveals that organizations with higher levels of employee experience see greater engagement, productivity, and innovation. However, only 41 percent of respondents rate their employee experience as 'very good.' Factors like camaraderie, purpose, and learning opportunities positively impact employee experience, while challenges such as heavy workloads and li...

A Kickstarter campaign has been launched to raise funds for a climate-smart platform that aims to support West African farmers in combating climate change effects, enhancing crop production, and securing food supplies for vulnerable communities. The platform will provide resources, training, and tools to boost productivity while protecting the environment. With promising results from pilot program...

Two researchers, Hortense Triniac and Katy Walsh, have been awarded the 2025 Ralph L. Sacco Scholarships for Brain Health. The $150,000 two-year scholarships will support Triniac's research on liver proteins and stroke risk reduction, and Walsh's investigation of cerebral amyloid angiopathy mechanisms. These scholarships are funded by the late Dr. Ralph L. Sacco's bequest to the American Academy o...

Angkor Resources Corp. has conducted a ground magnetic survey in the Andong Bor Copper Gold License in Cambodia, revealing magnetic anomalies that correlate with existing geochemical anomalies, indicating potential mineralization. The survey has identified priority zones for drilling efforts, paving the way for further exploration activities in the area.

ADIA Nutrition Inc. is revolutionizing the field of stem cell and regenerative medicine with advanced therapies and a commitment to expanding treatments. With plans for international expansion and innovative treatments like umbilical cord stem cells, ADIA is a stock to watch in the booming stem cell sector.

Nova Minerals is strategically positioned in Alaska's Tintina Gold Belt with its Estelle Gold and Critical Minerals Project. With efficient permitting processes and infrastructure advantages, Nova's dual-commodity approach of gold and antimony sets it apart in the industry, making it well-positioned for success in the evolving resource market.

Stonegate Capital Partners has initiated coverage on Lavras Gold Corp., highlighting the company's disciplined financial approach and successful exploration milestones. With a cash balance of C$1.65M and a recent C$15.0M raise, Lavras Gold is well-positioned to advance economic studies at key projects and transition to production. The company's experienced management team and focus on exploration...

Researchers have developed a probabilistic framework using percolation theory to evaluate cyber risks in drone swarms. This framework aids in insurance pricing and risk management for drone delivery systems, which is a rapidly growing market. The study highlights the importance of defense resources allocation and communication protocols in minimizing loss distribution under cyberattacks, providing...

Ace Therapeutics offers advanced cardiac organoid models that accurately mimic human heart properties, enabling high-throughput drug screening, early toxicity detection, and disease-specific modeling. These models expedite drug development, improve reliability, and drive innovation in cardiovascular research, reshaping the landscape of CVD research.

Synbio Concept is urging the USDA to adopt microbiome-based solutions and implement their 4-Layer Defense System to enhance biosecurity measures in the U.S. poultry industry. By targeting critical disease vectors and reducing reliance on chemicals, this proactive approach aims to prevent future crises and improve overall farm management practices.